The quality of conduct in Japanese clinical trials-Reference-Cited by-同舟云学术

The quality of conduct in Japanese clinical trials

Published:2002-02 Issue:1 Volume:23 Page:29-41
ISSN:0197-2456
Container-title:Controlled Clinical Trials
language:en
Short-container-title:Controlled Clinical Trials

Author:

Ono Shunsuke,Kodama Yasuo,Nagao Taku,Toyoshima Satoshi

Publisher

Elsevier BV

Subject

Pharmacology

Reference21 articles.

1. International comparison of conception on placebo use in clinical trials;Nakamura;Jpn J Clin Pharmacol Ther,1993

2. Clinical trials and the new good clinical practice guideline in Japan;Ono;Pharmacoeconomics,2000

3. International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline. Guideline for good clinical practice. Geneva: ICH-secretariat, 1996.

4. Recent findings in the GCP inspection;Kodama;Bulletin of Osaka Pharmaceutical Manufactures Association,2000

5. MHW Ordinance No. 28. March 27, 1997.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Errors Identified by Early, Risk-adapted, Triggered On-site Monitoring in Physician-initiated Clinical Trials not for Regulatory Approval in Cardiovascular Diseases;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2023-01-31

2. A descriptive research: Exclusion from submitted clinical data package in the review process of new drug approval due to GCP violation in Japan;Contemporary Clinical Trials Communications;2019-09

3. A Missing Piece in Clinical Trial Inspections in Latin America: Interviews With Research Subjects in Peru;Journal of Empirical Research on Human Research Ethics;2017-07-21

4. Surveillance of protocol deviations in Japanese oncology registration trials: a single institute experience;Investigational New Drugs;2017-02-01

5. Current situation of clinical trials in Beijing and Shanghai, China;Int. Journal of Clinical Pharmacology and Therapeutics;2013-05-01